{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:55:31Z","timestamp":1768740931527,"version":"3.49.0"},"reference-count":177,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T00:00:00Z","timestamp":1295913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis C virus (HCV) infection is a major health problem in patients with end\u2010stage renal disease (ESRD). The incidence of acute HCV infection during maintenance dialysis is much higher than that in the general population because of the risk of nosocomial transmission. Following acute HCV infection, most patients develop chronic HCV infection, and a significant proportion develop chronic hepatitis, cirrhosis, and even hepatocellular carcinoma. Overall, chronic hepatitis C patients on hemodialysis bear an increased risk of liver\u2010related morbidity and mortality, either during dialysis or after renal transplantation. Interferon (IFN) therapy is modestly effective for the treatment of HCV infection in ESRD patients. Conventional or pegylated IFN monotherapy has been used to treat acute hepatitis C in ESRD patients with excellent safety and efficacy. Regarding chronic hepatitis C, approximately one\u2010third of patients can achieve a sustained virological response (SVR) after conventional or pegylated IFN monotherapy. The combination of low\u2010dose ribavirin and conventional or pegylated IFN has further improved the SVR rate in treatment\u2010na\u00efve or retreated ESRD patients in clinical trials. Similar to the treatment of patients with normal renal function, baseline and on\u2010treatment HCV virokinetics are useful to guide optimized therapy in ESRD patients. Of particular note, IFN\u2010based therapy is not recommended at the post\u2010renal transplantation stage because of the low SVR rate and risk of acute graft rejection. In conclusion, ESRD patients with HCV infection should be encouraged to receive antiviral therapy, and those who achieve an SVR usually have long\u2010term, durable, virological, biochemical, and histological responses.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2010.06488.x","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T20:12:01Z","timestamp":1282075921000},"page":"228-239","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Treatment of hepatitis C virus infection in patients with end\u2010stage renal disease"],"prefix":"10.1111","volume":"26","author":[{"given":"Chen\u2010Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia\u2010Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,25]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00698.x"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03701.x"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20389"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/655682"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000013482"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02416.x"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/315869"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.385"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20415"},{"key":"e_1_2_11_11_2","first-page":"322","article-title":"Results of a national epidemiological investigation on HCV infection among dialysis patients (survey by the Italian branch of EDTNA\/ERCA)","volume":"12","author":"Lombardi M","year":"1999","journal-title":"J. Nephrol."},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(05)80017-4"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.09.021"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP58143"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1139\/w03-065"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-7-32"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20526"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2003.07.001"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00649.x"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70216-4"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00547.x"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31802dc57f"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhin.1999.0731"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/314850"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000049035"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/502058"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006070736"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.9.4321-4322.2004"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh012"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<44::AID-JMV7>3.0.CO;2-J"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186916"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.3.429"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.1.40"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186731"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000013523"},{"key":"e_1_2_11_36_2","first-page":"1356","article-title":"Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk","volume":"23","author":"Daw MA","year":"2002","journal-title":"Saudi. Med. J."},{"key":"e_1_2_11_37_2","first-page":"1","article-title":"Prevalence of hepatitis B and C viruses in a chronic hemodialysis center in Dakar","volume":"45","author":"Diouf ML","year":"2000","journal-title":"Dakar. Med."},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139880803101204"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027090"},{"key":"e_1_2_11_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.301"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.1998.00823.x"},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.6.1343"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00883.x"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(98)70027-7"},{"key":"e_1_2_11_45_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V11101896"},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.8.1669"},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh895"},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.07.004"},{"key":"e_1_2_11_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00868.x"},{"key":"e_1_2_11_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00853.x"},{"key":"e_1_2_11_51_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/089686080802800215","article-title":"Mortality in hepatitis C\u2010positive patients treated with peritoneal dialysis","volume":"28","author":"Wang SM","year":"2008","journal-title":"Perit. Dial. Int."},{"key":"e_1_2_11_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181574d58"},{"key":"e_1_2_11_53_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139880903200801"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199510000-00007"},{"key":"e_1_2_11_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199707270-00018"},{"key":"e_1_2_11_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199808270-00010"},{"key":"e_1_2_11_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199803150-00011"},{"key":"e_1_2_11_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290123"},{"key":"e_1_2_11_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000131948.29742.24"},{"key":"e_1_2_11_60_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.09.018"},{"key":"e_1_2_11_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.01.007"},{"key":"e_1_2_11_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.403"},{"key":"e_1_2_11_63_2","doi-asserted-by":"publisher","DOI":"10.1086\/315355"},{"key":"e_1_2_11_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.1.129"},{"key":"e_1_2_11_65_2","first-page":"308","article-title":"Clinicopathological features of hepatitis C virus infection in dialysis and renal transplantation","volume":"15","author":"Toz H","year":"2007","journal-title":"J. Nephrol."},{"key":"e_1_2_11_66_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.05.006"},{"key":"e_1_2_11_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.7.1804"},{"key":"e_1_2_11_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.6.1711-1715.1998"},{"key":"e_1_2_11_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01773.x"},{"key":"e_1_2_11_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70310-6"},{"key":"e_1_2_11_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21190"},{"key":"e_1_2_11_72_2","doi-asserted-by":"publisher","DOI":"10.1159\/000058398"},{"key":"e_1_2_11_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00417-7"},{"key":"e_1_2_11_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027359"},{"key":"e_1_2_11_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02195.x"},{"key":"e_1_2_11_76_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-9025-9"},{"key":"e_1_2_11_77_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm028"},{"key":"e_1_2_11_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.7.1394"},{"key":"e_1_2_11_79_2","first-page":"151","article-title":"High ALT levels predict viremia in anti\u2010HCV\u2010positive HD patients if a modified normal range of ALT is applied","volume":"54","author":"Espinosa M","year":"2000","journal-title":"Clin. Nephrol."},{"key":"e_1_2_11_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.1.180"},{"key":"e_1_2_11_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2005.09.010"},{"key":"e_1_2_11_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01649.x"},{"key":"e_1_2_11_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200208000-00013"},{"key":"e_1_2_11_84_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01330308"},{"key":"e_1_2_11_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328313bbc1"},{"key":"e_1_2_11_86_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102153440706"},{"key":"e_1_2_11_87_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22742"},{"key":"e_1_2_11_88_2","first-page":"442","article-title":"Percutaneous liver biopsy complications in patients with chronic renal failure","volume":"74","author":"Ozdo\u011fan M","year":"2006","journal-title":"Nephron"},{"key":"e_1_2_11_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.07.010"},{"key":"e_1_2_11_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hep.2003.09.022"},{"key":"e_1_2_11_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21681"},{"key":"e_1_2_11_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.74"},{"key":"e_1_2_11_93_2","first-page":"23","article-title":"Transient elastography for the assessment of hepatic fibrosis in hemodialysis patients with chronic hepatitis C","volume":"4","author":"Liu CH","year":"2010","journal-title":"Hepatol. Int."},{"key":"e_1_2_11_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22759"},{"key":"e_1_2_11_95_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240405"},{"key":"e_1_2_11_96_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011232"},{"key":"e_1_2_11_97_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20196"},{"key":"e_1_2_11_98_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045065"},{"key":"e_1_2_11_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2001.00268.x"},{"key":"e_1_2_11_100_2","doi-asserted-by":"publisher","DOI":"10.1159\/000079871"},{"key":"e_1_2_11_101_2","first-page":"293","article-title":"Treatment of acute hepatitis C virus infection with alpha interferon in patients on hemodialysis","volume":"16","author":"Al\u2010Harbi AS","year":"2005","journal-title":"Saudi. J. Kidney. Dis. Transplant."},{"key":"e_1_2_11_102_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.meg.0000252626.73172.f3"},{"key":"e_1_2_11_103_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-7-50"},{"key":"e_1_2_11_104_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21197"},{"key":"e_1_2_11_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.021"},{"key":"e_1_2_11_106_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.197"},{"key":"e_1_2_11_107_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.198"},{"key":"e_1_2_11_108_2","first-page":"1834","article-title":"Interferon\u2010alpha 2b treatment of chronic hepatitis C in haemodialysis patients","volume":"10","author":"Raptopoulou\u2010Gigi M","year":"1995","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_11_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.1997.tb00213.x"},{"key":"e_1_2_11_110_2","doi-asserted-by":"publisher","DOI":"10.1086\/517339"},{"key":"e_1_2_11_111_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.7.1414"},{"key":"e_1_2_11_112_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045125"},{"key":"e_1_2_11_113_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007999809113353"},{"key":"e_1_2_11_114_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045035"},{"key":"e_1_2_11_115_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045363"},{"key":"e_1_2_11_116_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.11.2704"},{"key":"e_1_2_11_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70108-3"},{"key":"e_1_2_11_118_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045971"},{"key":"e_1_2_11_119_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03697.x"},{"key":"e_1_2_11_120_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.5.1017"},{"key":"e_1_2_11_121_2","first-page":"220","article-title":"Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long\u2010term sustained virological and biochemical response","volume":"55","author":"Espinosa M","year":"2001","journal-title":"Clin. Nephrol."},{"key":"e_1_2_11_122_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000079613.81511.3C"},{"key":"e_1_2_11_123_2","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-200031725"},{"key":"e_1_2_11_124_2","doi-asserted-by":"publisher","DOI":"10.1159\/000085442"},{"key":"e_1_2_11_125_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.02.054"},{"key":"e_1_2_11_126_2","first-page":"338","article-title":"Tolerance and efficacy of interferon\u2010alpha in hemodialysis patients in Tripoli","volume":"17","author":"Buargub M","year":"2006","journal-title":"Saudi. J. Kidney. Dis. Transpl."},{"key":"e_1_2_11_127_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01225.x"},{"key":"e_1_2_11_128_2","doi-asserted-by":"publisher","DOI":"10.1159\/000090505"},{"key":"e_1_2_11_129_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.133884"},{"key":"e_1_2_11_130_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01780.x"},{"key":"e_1_2_11_131_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07526.x"},{"key":"e_1_2_11_132_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00907.x"},{"key":"e_1_2_11_133_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.11.003"},{"key":"e_1_2_11_134_2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1681\/ASN.V9122344","article-title":"Pharmacokinetics of alphaIFN\u20102b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications","volume":"9","author":"Rostaing L","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_11_135_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01954.x"},{"key":"e_1_2_11_136_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh747"},{"key":"e_1_2_11_137_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i26.4191"},{"key":"e_1_2_11_138_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.04008.x"},{"key":"e_1_2_11_139_2","first-page":"794","article-title":"Analysis of safety and efficacy of pegylated\u2010interferon alpha\u20102a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit","volume":"19","author":"Covic A","year":"2006","journal-title":"J. Nephrol."},{"key":"e_1_2_11_140_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi231"},{"key":"e_1_2_11_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.07.013"},{"key":"e_1_2_11_142_2","first-page":"16","article-title":"Monotherapy with peginterferon alpha\u20102b {12\u2003kDa} for chronic hepatitis C infection in patients undergoing haemodialysis","volume":"28","author":"Amarapurkar DN","year":"2007","journal-title":"Trop. Gastroenterol."},{"key":"e_1_2_11_143_2","doi-asserted-by":"publisher","DOI":"10.1080\/08860220701641579"},{"key":"e_1_2_11_144_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00662.x"},{"key":"e_1_2_11_145_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP67366"},{"key":"e_1_2_11_146_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.255"},{"key":"e_1_2_11_147_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-008-7134-z"},{"key":"e_1_2_11_148_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0016-z"},{"key":"e_1_2_11_149_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01191.x"},{"key":"e_1_2_11_150_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21542"},{"key":"e_1_2_11_151_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01850309"},{"key":"e_1_2_11_152_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012073432301"},{"key":"e_1_2_11_153_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26371"},{"key":"e_1_2_11_154_2","doi-asserted-by":"publisher","DOI":"10.1177\/009127002237996"},{"key":"e_1_2_11_155_2","first-page":"326A","article-title":"40\u2003kDa peginterferon alfa\u20102a (Pegasys@) can be administered safety in patients with end\u2010stage renal disease","volume":"34","author":"Lamb TW","year":"2001","journal-title":"Hepatology"},{"key":"e_1_2_11_156_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392101"},{"key":"e_1_2_11_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07124-4"},{"key":"e_1_2_11_158_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2001.00300.x"},{"key":"e_1_2_11_159_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.1.193"},{"key":"e_1_2_11_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.07.025"},{"key":"e_1_2_11_161_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00680.x"},{"key":"e_1_2_11_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.12.016"},{"key":"e_1_2_11_163_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139880803100404"},{"key":"e_1_2_11_164_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm724"},{"key":"e_1_2_11_165_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318180803a"},{"key":"e_1_2_11_166_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.165076"},{"key":"e_1_2_11_167_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_2_11_168_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_2_11_169_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03151.x"},{"key":"e_1_2_11_170_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199504150-00030"},{"key":"e_1_2_11_171_2","doi-asserted-by":"publisher","DOI":"10.1159\/000189444"},{"key":"e_1_2_11_172_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00422-0"},{"key":"e_1_2_11_173_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000128911.87538.AA"},{"key":"e_1_2_11_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2003.10.001"},{"key":"e_1_2_11_175_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2007.02.006"},{"key":"e_1_2_11_176_2","doi-asserted-by":"publisher","DOI":"10.1159\/000046646"},{"key":"e_1_2_11_177_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4318\/tjg.2009.0020","article-title":"The quality of life in hemodialysis patients with chronic hepatitis C virus infection","volume":"20","author":"Aky\u00fcz F","year":"2009","journal-title":"Turk. J. Gastroenterol."},{"key":"e_1_2_11_178_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139880903200309"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2010.06488.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2010.06488.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T03:01:09Z","timestamp":1697338869000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2010.06488.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,25]]},"references-count":177,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1440-1746.2010.06488.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06488.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,25]]},"assertion":[{"value":"2011-01-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}